Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
06
2020
accepted:
22
12
2020
entrez:
13
1
2021
pubmed:
14
1
2021
medline:
11
5
2021
Statut:
epublish
Résumé
Increasing reports of azole resistance in Candida tropicalis, highlight the development of rapid resistance detection techniques. Nonsynonymous mutations in the lanosterol C14 alpha-demethylase (ERG11) gene is one of the predominant mechanisms of azole resistance in C. tropicalis. We evaluated the tetra primer-amplification refractory mutation system-PCR (T-ARMS-PCR), restriction site mutation (RSM), and high-resolution melt (HRM) analysis methods for rapid resistance detection based on ERG11 polymorphism in C. tropicalis. Twelve azole-resistant and 19 susceptible isolates of C. tropicalis were included. DNA sequencing of the isolates was performed to check the ERG11 polymorphism status among resistant and susceptible isolates. Three approaches T-ARMS-PCR, RSM, and HRM were evaluated and validated for the rapid detection of ERG11 mutation. The fluconazole MICs for the 12 resistant and 19 susceptible isolates were 32-256 mg/L and 0.5-1 mg/L, respectively. The resistant isolates showed A339T and C461T mutations in the ERG11 gene. The T-ARMS-PCR and RSM approaches discriminated all the resistant and susceptible isolates, whereas HRM analysis differentiated all except one susceptible isolate. The sensitivity, specificity, analytical sensitivity, time, and cost of analysis suggests that these three methods can be utilized for the rapid detection of ERG11 mutations in C. tropicalis. Additionally, an excellent concordance with DNA sequencing was noted for all three methods. The rapid, sensitive, and inexpensive T-ARMS-PCR, RSM, and HRM approaches are suitable for the detection of azole resistance based on ERG11 polymorphism in C. tropicalis and can be implemented in clinical setups for batter patient management.
Identifiants
pubmed: 33439909
doi: 10.1371/journal.pone.0245160
pii: PONE-D-20-17635
pmc: PMC7806177
doi:
Substances chimiques
Azoles
0
Fungal Proteins
0
Cytochrome P-450 Enzyme System
9035-51-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0245160Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Antimicrob Chemother. 2017 Apr 1;72(4):988-992
pubmed: 28065893
Intensive Care Med. 2017 May;43(5):652-662
pubmed: 28321466
Med Mycol. 2011 Jan;49(1):10-5
pubmed: 20586679
Iran J Biotechnol. 2017 Sep 27;15(3):208-212
pubmed: 29845071
Antimicrob Resist Infect Control. 2020 Apr 7;9(1):50
pubmed: 32264966
Front Microbiol. 2017 Mar 22;8:464
pubmed: 28382028
J Antimicrob Chemother. 2013 Apr;68(4):778-85
pubmed: 23221625
Curr Opin Infect Dis. 2009 Dec;22(6):568-73
pubmed: 19741524
Emerg Microbes Infect. 2017 Oct 11;6(10):e87
pubmed: 29018251
BMC Res Notes. 2018 Feb 15;11(1):132
pubmed: 29448951
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6573-6577
pubmed: 27550360
Front Microbiol. 2017 Jan 12;7:2173
pubmed: 28127295
Med Mycol. 2020 Aug 1;58(6):766-773
pubmed: 31828316
Mol Biotechnol. 2014 Jul;56(7):599-608
pubmed: 24519268
Clin Microbiol Infect. 2015 Apr;21(4):372-8
pubmed: 25658527
Clin Chem. 2000 May;46(5):631-5
pubmed: 10794744
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30397051
Folia Microbiol (Praha). 2010 May;55(3):301-4
pubmed: 20526846
Antimicrob Agents Chemother. 2013 Jul;57(7):3182-93
pubmed: 23629718
Intensive Care Med. 2015 Feb;41(2):285-95
pubmed: 25510301
Front Microbiol. 2020 Jan 14;10:2903
pubmed: 31993022
J Infect Chemother. 2012 Oct;18(5):741-6
pubmed: 22526385
Front Microbiol. 2017 Oct 13;8:1927
pubmed: 29081766
Lancet Infect Dis. 2017 Dec;17(12):e383-e392
pubmed: 28774698
Sci Rep. 2020 Jan 28;10(1):1297
pubmed: 31992797
Curr Microbiol. 2016 Aug;73(2):172-82
pubmed: 27107760
Clin Chim Acta. 2012 Jul 11;413(13-14):1092-7
pubmed: 22445829
J Mol Diagn. 2010 Jan;12(1):91-101
pubmed: 20007848
Clin Microbiol Infect. 2019 Jul;25(7):885-891
pubmed: 30472420
Mol Cell Probes. 2011 Aug;25(4):177-81
pubmed: 21530640
Mycopathologia. 2015 Apr;179(3-4):213-8
pubmed: 25398256
Antimicrob Agents Chemother. 2016 May 23;60(6):3653-61
pubmed: 27044550
Diagn Microbiol Infect Dis. 2014 Jun;79(2):198-204
pubmed: 24736096
Mutat Res. 1998 Sep 20;405(2):209-20
pubmed: 9748583
BMC Microbiol. 2009 Aug 14;9:167
pubmed: 19682357
Emerg Infect Dis. 2019 Sep;25(9):1660-1667
pubmed: 31441426
J Glob Antimicrob Resist. 2020 Sep;22:553-561
pubmed: 32339847
Mutat Res. 1996 Jun 12;353(1-2):109-21
pubmed: 8692187